A retrospective review by Hendriks et al. analyzed 19 patients with LMD from non-small cell lung cancer (NSCLC) treated with intravenous (IV) ICIs, including PDL-1 inhibitors with or without anti-CTLA4 antibodies [18]. The gene discussed is CD274; the disease is Langer mesomelic dysplasia.